OBJECTIVE: Prospective case-control study, undertaken to investigate serum cytokine and chemokine concentrations during all clinical phases and in different clinical types of haemorrhagic fever with renal syndrome (HFRS). METHODS: Serum was collected at various disease phases from patients with HFRS (n = 35) and healthy control subjects (n = 10). Tumour necrosis factor (TNF)-a, interleukin (IL)-6, IL-4, interferon (IFN)-g, IL-8, interferon inducible protein-10 (IP-10) and chemokine (C-C motif) ligand 5 (also known as 'regulated upon activation, normal T-cell expressed and secreted' [RANTES]) were quantified using commercial enzymelinked immunosorbent assay kits. RESULTS: Serum concentrations of TNF-a, IL-6, IFN-g, IL-8, IP-10 and RANTES (but not IL-4) were significantly higher in patients compared with controls. Highest concentrations were generally found during the febrile, hypotensive and oliguric disease phases, as well as in clinically severe and critical cases. CONCLUSION: Serum concentrations of proinflammatory cytokines and chemokines increased in line with disease severity in HFRS patients.
Introduction
Hantavirus is transmitted from its natural hosts (rodents) to humans via inhalation of aerosolized virus-contaminated excreta. 1 Hantavirus infection causes two severe diseases in humans: haemorrhagic fever with renal syndrome (HFRS) in Europe and Asia; hantavirus pulmonary syndrome (HPS) in the Americas. 2 Haemorrhagic fever with renal syndrome, which is endemic in Europe and Asia, is caused by Hantaan virus (HTNV), Seoul virus, Dobrava virus and Puumala virus (PUUV), each of which causes diseases of differing severity. 2 Each virus has a specific rodent reservoir and characteristic geographical a P-Z Wang and Z-D Li contributed equally to this work.
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distribution. 3 The worldwide annual incidence of HFRS is > 100 000 cases, > 50% of which are documented in mainland China, and it has a worldwide annual mortality rate of 2 -10%. 4, 5 The predominant symptoms of HFRS are sudden high fever, severe lumbalgia, proteinuria and thrombocytopenia. Typical cases have five successive phases: febrile; hypotensive; oliguric; diuretic; convalescent. 6, 7 There is evidence to suggest that serious vascular leakage is central to the pathogenesis of hantavirus infection, 2, 8 probably mediated by host-related immunopathological mechanisms rather than direct viral cytopathology. 9 Evidence from several laboratories supports the general hypothesis that HFRS is caused by elevated CD8 + T-cell responses 10 -12 and excessively high levels of proinflammatory cytokines (known as the 'cytokine storm' or 'hypercytokinaemia'). 13 -16 Cytokines play important roles in shaping and maintaining the immune response. Secreted mediators may facilitate the migration of immune cells from the bloodstream to the site of infection, resulting in different immunoreactions. 17 Increased levels of cytokines and chemokines have been observed in viral infections such as dengue fever and influenza. 18, 19 Studies indicate that some cytokines and chemokines -including chemokine (C-C motif) ligand 5 (also known as 'regulated upon activation, normal T-cell expressed and secreted' [RANTES]), interferon inducible protein (IP)-10, tumour necrosis factor (TNF)-α, and interleukin (IL)-6 -play key roles in hantavirus infections. 14, 16, 20, 21 Little is known, however, about the dynamic changes in circulating cytokine and chemokine concentrations at different clinical phases and in different clinical types of HFRS.
The aim of this study was to quantify the serum concentrations of TNF-α, IL-4, IL-6, IL-8, interferon (IFN)-γ, IP-10 and RANTES in patients during all clinical phases and in different clinical types of HFRS, and compare them with serum concentrations in healthy control subjects. Patients were characterized according to the Prevention and Treatment Strategy of HFRS 22 prior to discharge from hospital. Clinical type classification (mild, medium, severe, critical) was based on severity of fever and toxaemic symptoms, blood pressure, extent of haemorrhage, severity of kidney damage and functional insufficiency (proteinuria, occurrence and duration of oliguric period, and urea nitrogen concentration), and occurrence and severity of complications. 22 All patients were managed according to the published guidelines; 22 none received corticosteroids or other immunomodulatory drugs during the study period.
Patients and methods
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A group of healthy volunteers recruited from the local population of Xi'an, Shaanxi Province, China was included as the control group.
The study protocol conformed with the Declaration of Helsinki (2008 version) and was approved by the Ethics Committee of Tangdu Hospital. Written informed consent was obtained from all study participants.
SERUM SAMPLES
Venous blood was collected once from healthy controls, and from HFRS patients during each disease phase (febrile, hypotensive, oliguric, diuretic and convalescent). Blood samples were drawn into tubes without anticoagulant, allowed to clot at room temperature for 30 -60 min and centrifuged at 500 g for 10 min. Aliquots of serum were stored at -70°C and thawed immediately before being assayed.
CYTOKINE AND CHEMOKINE ELISA
Serum concentrations of TNF-α, IL-4, IL-6, IL-8, IFN-γ and RANTES were quantified using commercially available ELISA kits (GenWay Biotech, San Diego, CA, USA), according to the manufacturer's instructions. IP-10 was quantified using an ELISA kit from Adlitteram Diagnostic Laboratories (San Diego, CA, USA), according to the manufacturer's instructions. Optical density was measured using a microplate reader (Model 680; Bio-Rad, Hercules, CA, USA) at 450 nm for IP-10 and at 490 nm for all other cytokines and chemokines.
STATISTICAL ANALYSES
Data were presented as mean ± SD. Betweengroup comparisons of cytokine and chemokine concentrations were performed using the Kruskal-Wallis test. All data were analysed using SPSS ® version 12.0 (SPSS Inc., Chicago, IL, USA) for Windows ® . A P-value < 0.05 was considered statistically significant.
Results
The study recruited 35 patients with HFRS (27 males and eight females; median age 38.6 years [range 16 -75 years]) and 10 healthy volunteers (seven males and three females; median age 29 years [range 21 -46 years]). Patients with HFRS included eight mild, 14 medium, nine severe and four critical cases. A total of 75 of a possible 175 serum samples were obtained from patients; the deficit was due to discharge from hospital or death prior to sampling.
Serum concentrations of TNF-α, IL-4, IL-6, IL-8, IFN-γ, IP-10 and RANTES at different disease phases of HFRS, and in healthy controls, are given in Table 1 . The serum concentrations of TNF-α, IL-6, IL-8, IFN-γ, IP-10 and RANTES were significantly higher in patients with HFRS in all disease phases except convalescence, compared with the serum concentrations in healthy control subjects (P < 0.05 for all comparisons). There were significant between-phase differences in serum concentrations of TNF-α, IL-6, IL-8, IFN-γ, IP-10 and RANTES, with the exception of the hypotensive versus oliguric phases (P < 0.05 for all comparisons). There were no significant differences in serum concentrations of IL-4 between controls and patients, at any disease phase.
Serum concentrations of TNF-α, IL-4, IL-6, IL-8, IFN-γ, IP-10 and RANTES in different clinical types of HFRS are given in Table 2 . The concentrations of TNF-α, IL-6, IL-8, IFN-γ, IP-10 and RANTES generally increased in line with disease severity and were significantly higher in patients with HFRS of all clinical types than in controls (P < 0.05 for all comparisons). There were significant between-type differences in the concentrations of TNF-α, IL-6, IL-8, IFN-γ, IP-10 and RANTES, with the exception of severe versus critical types (P < 0.05 for all comparisons). There were no significant differences in IL-4 concentrations Data presented as mean ± SD. TNF-α, tumour necrosis factor-α; IL, interleukin; IFN, interferon; IP-10, interferon inducible protein-10; RANTES, 'regulated upon activation, normal T-cell expressed and secreted', also known as chemokine (C-C motif) ligand 5.
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TABLE 2: Serum concentrations of inflammatory cytokines and chemokines throughout the disease course in patients with haemorrhagic fever with renal syndrome (HFRS) of different clinical types (mild, medium, severe and critical 22
) and healthy control subjects Inflammatory cytokines and chemokines in HFRS between any of the four HFRS clinical types and the healthy control subjects.
Discussion
The major pathophysiological changes of HFRS are vascular endothelial cell injury, increased capillary permeability, acute renal failure and haemorrhage, 2, 8 suggesting that serious vascular leakage is central to the pathogenesis of hantavirus infections. There is no evidence to suggest, however, that hantavirus infection of vascular endothelial cells directly causes obvious cell damage or morphological alteration. 23 -25 Immune mechanisms, rather than direct viral cytopathology, appear to be responsible for the changes in vascular permeability. 8, 26 Several hypotheses have been proposed to explain the mechanism of increased capillary permeability, including the role of HTNV-specific cytotoxic T lymphocytes (CTL), TNF-α, cytokine storm, β 3 -integrin regulation and platelet dysfunction. 27 It is likely that several mechanisms contribute to hantavirus disease and that different components may contribute dynamically to specific aspects of pathogenesis. It is thought that injury to vascular endothelial cells is caused by an immune response that kills or injures the infected cells during the elimination of HTNV. 9, 28 The immune mechanisms underlying the development of hantavirus symptoms and lesions remain largely unknown, however.
Cytokines are important mediators of the immune response. In particular, the response to virus infection relies on the early production of cytokines that induce an antiviral state and trigger the activation of immune cells. 29 The present study found significant changes in serum concentrations of TNF-α, IL-6, IL-8, IFNγ, IP-10 and RANTES in patients as they progressed through the different phases of HFRS; higher concentrations were observed in more severe disease types. These elevated concentrations of circulating cytokines and chemokines may have resulted from the activation of immune cells: this activation may have led to enhanced synthesis and release of cytokines and chemokines.
Tumour necrosis factor-α and IL-6 are important proinflammatory cytokines. Increased levels of TNF-α and IL-6 have been detected in nephropathia epidemica, which is a mild-to-moderate form of HFRS where TNFα concentrations correlate with hypotension and serum nitric oxide concentration, and plasma IL-6 concentration is associated with more severe disease. 16, 30 In addition, cynomolgus monkeys infected with wild-type PUUV have demonstrated increased TNF-α production, with the highest concentrations detected in the most severely affected animals. 31 High serum TNF-α concentrations were also found in patients with severe dengue haemorrhagic fever or Argentine haemorrhagic fever, which have similar clinical presentations to HFRS. 32 -34 Increased serum concentrations of TNF-α and IL-6 were found in patients with HFRS in the present study, with higher concentrations observed during the more severe clinical phases of disease (i.e. the hypotensive and oliguric phases) and in patients with more severe clinical disease types (severe and critical cases). The similar phase-and type-specific changes observed in TNF-α and IL-6 concentrations may be explained by the fact that IL-6 production is induced by TNF-α. 35 Interferon-γ is the major proinflammatory cytokine associated with the helper T-cell (Th1) pattern of cytokine expression. 36 Serum IFN-γ concentrations were significantly increased in patients with HFRS during the febrile, hypotensive and oliguric phases, as well as in patients with medium, severe and critical disease types in the present study. The highest IFN-γ concentration was observed in P-Z Wang, Z-D Li, H-T Yu et al.
Inflammatory cytokines and chemokines in HFRS
the febrile phase, suggesting early Th1 activation in HFRS. Our research group has previously reported IFN-γ-specific T-cell responses against HTNV nucleocapsid protein in patients with HFRS. 12 Interleukin-4 downregulates inflammatory reactions and is the major antiinflammatory cytokine associated with the Th2 pattern of cytokine expression. 36 There were no significant differences in IL-4 concentrations between the HFRS phases, clinical types, or between patients and controls, in the present study. Other research has reported a marked increase in the proportions of Th1 and CTL in patients with HFRS, 37 suggesting that preferential Th1 proliferation and differentiation occurs in HTNV-infected individuals, and that Th1 cells may play a role in the resolution of HTNV because HFRS is a fulminant but selfconstrained disease.
Interferon inducible protein-10, RANTES and IL-8 are important chemokines. Both IP-10 and RANTES are predominantly chemotactic for mononuclear leucocytes, 20, 38 and IP-10 has been shown to be essential in the development of a protective Th1 response against viral infections in the central nervous system. 39 In both HFRS and HPS there is evidence of a Th1-type immune response that is characterized by elevated levels of serum IFN-γ. 4,15 IL-8 is a neutrophil chemotactic factor that also increases adherence to endothelial cells and transendothelial migration. 40, 41 In addition to the direct chemotactic effect on T cells, IL-8 indirectly causes T-cell chemotaxis by inducing neutrophils to release several factors that have chemotactic activities against T cells, such as defensin-1 and defensin-2. 42 Interestingly, the production of IL-8 and IP-10 has been shown to be elevated during severe acute respiratory syndrome coronavirus infection, and is believed to be involved in the pathogenesis of severe acute respiratory syndrome, 43 in addition to other viral infections. 44 Infection with the HPS-causing Sin Nombre hantavirus has been shown to increase the production of IP-10 in human lung microvascular endothelial cells, and a synergistic effect on IP-10 production has been described for both Sin Nombre and the HFRS-causing HTNV, when combined with IFN-γ stimulation of the same cells. 20 Elevated IP-10, RANTES and IL-8 concentrations were detected in patients with HFRS in the febrile, hypotensive and oliguric phases of disease in the present study, as well as in patients with severe or critical disease. It is possible that hantavirus infection directs and enhances the effector immune response to the infected microvascular endothelium via the selective activation of RANTES and IP-10.
The results of the present study suggest that increased concentrations of circulating cytokines and chemokines -and an imbalance in the production of pro-and anti-inflammatory cytokines -may be associated with disease severity in HFRS. A similar pathological mechanism has been proposed for HPS, where a mixed Th1/Th2 immune response was observed in serum, and levels of Th1 cytokines correlated with disease severity. 45 A strong inflammatory response to hantavirus particles and immune complexes (mainly represented by TNF-α and IFN-γ), with consequent changes in vascular permeability, may contribute to a severe clinical course in HFRS. Inflammatory cytokines and chemokines represent a double-edged sword, directly and indirectly contributing to viral elimination by inducing and amplifying the innate effector function and antigen presentation of viral epitopes to T cells, but also facilitating an immunopathological process in virusassociated diseases.
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